This company has been marked as potentially delisted and may not be actively trading. Tocagen (TOCA) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock TOCA vs. ZYME, CALT, MBX, ETHZ, SBTX, AVTE, BIOA, NLTX, CYBN, and VIRIShould you be buying Tocagen stock or one of its competitors? The main competitors of Tocagen include Zymeworks (ZYME), Calliditas Therapeutics AB (publ) (CALT), MBX Biosciences (MBX), Flag Ship Acquisition (ETHZ), Silverback Therapeutics (SBTX), Aerovate Therapeutics (AVTE), BioAge Labs (BIOA), Neoleukin Therapeutics (NLTX), Cybin (CYBN), and Virios Therapeutics (VIRI). Tocagen vs. Its Competitors Zymeworks Calliditas Therapeutics AB (publ) MBX Biosciences Flag Ship Acquisition Silverback Therapeutics Aerovate Therapeutics BioAge Labs Neoleukin Therapeutics Cybin Virios Therapeutics Tocagen (NASDAQ:TOCA) and Zymeworks (NASDAQ:ZYME) are both small-cap pharmaceutical preparations industry companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and media sentiment. Do analysts prefer TOCA or ZYME? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tocagen 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Zymeworks 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Do institutionals and insiders hold more shares of TOCA or ZYME? 21.4% of Tocagen shares are held by institutional investors. Comparatively, 92.9% of Zymeworks shares are held by institutional investors. 10.9% of Tocagen shares are held by insiders. Comparatively, 1.9% of Zymeworks shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is TOCA or ZYME more profitable? Zymeworks has a net margin of -59.96% compared to Tocagen's net margin of -176,433.34%. Zymeworks' return on equity of -21.59% beat Tocagen's return on equity.Company Net Margins Return on Equity Return on Assets Tocagen-176,433.34% -327.74% -111.87% Zymeworks -59.96%-21.59%-16.52% Does the media refer more to TOCA or ZYME? In the previous week, Zymeworks had 2 more articles in the media than Tocagen. MarketBeat recorded 2 mentions for Zymeworks and 0 mentions for Tocagen. Zymeworks' average media sentiment score of 0.30 beat Tocagen's score of 0.00 indicating that Zymeworks is being referred to more favorably in the news media. Company Overall Sentiment Tocagen Neutral Zymeworks Neutral Which has better earnings and valuation, TOCA or ZYME? Tocagen has higher earnings, but lower revenue than Zymeworks. Zymeworks is trading at a lower price-to-earnings ratio than Tocagen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTocagen$40K8,509.18-$63.52M-$2.69-5.29Zymeworks$76.30M16.43-$122.69M-$0.97-17.20 Which has more volatility & risk, TOCA or ZYME? Tocagen has a beta of 0.01, suggesting that its stock price is 99% less volatile than the S&P 500. Comparatively, Zymeworks has a beta of 1.51, suggesting that its stock price is 51% more volatile than the S&P 500. SummaryZymeworks beats Tocagen on 10 of the 14 factors compared between the two stocks. Get Tocagen News Delivered to You Automatically Sign up to receive the latest news and ratings for TOCA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TOCA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TOCA vs. The Competition Export to ExcelMetricTocagenPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$340.37M$1.05B$6.11B$10.56BDividend YieldN/A4.84%5.69%4.75%P/E Ratio-6.001.2685.4827.60Price / Sales8,509.1828.98621.72242.93Price / CashN/A17.6437.9261.55Price / Book31.627.5213.136.76Net Income-$63.52M-$7.77M$3.30B$275.88M Tocagen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TOCATocagenN/A$14.23-1.4%N/A+187.5%$340.37M$40K-6.0077ZYMEZymeworks0.0736 of 5 stars$16.94-0.8%N/AN/A$1.27B$122.87M-17.46460News CoverageAnalyst ForecastCALTCalliditas Therapeutics AB (publ)N/A$40.00flatN/AN/A$1.19B$1.60B-21.62180MBXMBX BiosciencesN/A$17.90+2.3%$39.88+122.8%N/A$601.33MN/A-3.9436ETHZFlag Ship AcquisitionN/A$2.38-1.2%N/AN/A$391.34MN/A-0.167News CoverageAnalyst ForecastSBTXSilverback TherapeuticsN/A$10.05+3.4%N/A-27.6%$362.38MN/A-4.1583High Trading VolumeAVTEAerovate TherapeuticsN/A$8.63+0.1%N/A-87.4%$250.14MN/A-2.8920High Trading VolumeBIOABioAge Labs0.1863 of 5 stars$5.92+0.7%N/AN/A$212.23MN/A0.00N/ANews CoverageAnalyst ForecastNLTXNeoleukin TherapeuticsN/A$17.71-0.6%N/A-51.4%$166.44MN/A-5.6990High Trading VolumeCYBNCybinN/A$5.98+1.5%$85.00+1,321.4%N/A$150.62MN/A-1.3650High Trading VolumeVIRIVirios TherapeuticsN/A$7.70-2.7%$5.00-35.1%+4,751.3%$148.29MN/A-28.525 Related Companies and Tools Related Companies Zymeworks Alternatives Calliditas Therapeutics AB (publ) Alternatives MBX Biosciences Alternatives Flag Ship Acquisition Alternatives Silverback Therapeutics Alternatives Aerovate Therapeutics Alternatives BioAge Labs Alternatives Neoleukin Therapeutics Alternatives Cybin Alternatives Virios Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TOCA) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tocagen Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Tocagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
